Newsbenzinga
Addex Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript
· Published
Article summary
Addex Therapeutics (NASDAQ:ADXN) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. Benzinga APIs provide real-time access to
An excerpt from the original article.
Comments —
Loading comments…